The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico-Reference-Cited by-同舟云学术

The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico

Published:2019-12 Issue: Volume:20 Page:129-135
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Moye-Holz Daniela,van Dijk Jitse P.,Reijneveld Sijmen A.,Hogerzeil Hans V.

Funder

National Council of Science and Technology

Consejo Nacional de Ciencia y Tecnología

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference52 articles.

1. New drug treatments for cancer: what the future holds;Buckland;Prescriber,2016

2. Essential medicines for cancer: WHO recommendations and national priorities;Robertson;Bull World Health Organ,2016

3. Accessibility to targeted oncology drugs in Slovenia and selected European countries;Kos;Eur J Cancer,2008

4. Improving access to high-cost cancer drugs in Latin America: much to be done;Ruiz;Cancer,2017

5. Barriers to access and use of high cost medicines: a review;Wahlster;Health Policy Technology,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective;BMC Public Health;2024-08-21

2. Medicines policy, access and use in Mexico: a systematic literature review 2000–2022;Drugs in Context;2024-02-12

3. Access to anticancer medicines in public hospitals of Northwestern China;Frontiers in Public Health;2023-05-19

4. High cost drugs in Latin America: access and barriers;Expert Review of Pharmacoeconomics & Outcomes Research;2023-04-28

5. Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China;INQUIRY: The Journal of Health Care Organization, Provision, and Financing;2023-01